IRIS
BOCCANEGRA, BRIGIDA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.425
EU - Europa 740
AS - Asia 705
SA - Sud America 174
Continente sconosciuto - Info sul continente non disponibili 112
AF - Africa 39
OC - Oceania 2
Totale 3.197
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.327
IT - Italia 400
SG - Singapore 310
BR - Brasile 131
CN - Cina 116
HK - Hong Kong 75
CA - Canada 69
DE - Germania 63
RU - Federazione Russa 61
VN - Vietnam 61
FR - Francia 42
GB - Regno Unito 41
FI - Finlandia 26
ID - Indonesia 24
SE - Svezia 24
BD - Bangladesh 22
ES - Italia 21
IN - India 21
MX - Messico 21
NL - Olanda 16
JP - Giappone 13
CI - Costa d'Avorio 12
AR - Argentina 11
IQ - Iraq 11
AT - Austria 8
TR - Turchia 8
CZ - Repubblica Ceca 7
MA - Marocco 7
PK - Pakistan 7
ZA - Sudafrica 7
CO - Colombia 6
PL - Polonia 6
UA - Ucraina 6
VE - Venezuela 6
EC - Ecuador 5
PE - Perù 5
CL - Cile 4
JO - Giordania 4
MY - Malesia 4
TW - Taiwan 4
UZ - Uzbekistan 4
IE - Irlanda 3
IL - Israele 3
KE - Kenya 3
AZ - Azerbaigian 2
BE - Belgio 2
BO - Bolivia 2
CH - Svizzera 2
CR - Costa Rica 2
DK - Danimarca 2
DZ - Algeria 2
EE - Estonia 2
EG - Egitto 2
GR - Grecia 2
GT - Guatemala 2
KR - Corea 2
NI - Nicaragua 2
NP - Nepal 2
PY - Paraguay 2
SA - Arabia Saudita 2
TN - Tunisia 2
AL - Albania 1
AO - Angola 1
AU - Australia 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BS - Bahamas 1
BT - Bhutan 1
GA - Gabon 1
GE - Georgia 1
GP - Guadalupe 1
GY - Guiana 1
KG - Kirghizistan 1
KH - Cambogia 1
KZ - Kazakistan 1
LB - Libano 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
OM - Oman 1
PH - Filippine 1
PT - Portogallo 1
RO - Romania 1
RS - Serbia 1
SC - Seychelles 1
SK - Slovacchia (Repubblica Slovacca) 1
SZ - Regno dello Swaziland 1
UY - Uruguay 1
Totale 3.085
Salva come PNG Salva come JPEG
Città #
Ashburn 215
Singapore 187
San Jose 158
Bari 113
Council Bluffs 83
Dallas 75
Hong Kong 73
Milan 66
Chandler 44
Beijing 40
Los Angeles 33
Fairfield 29
Victoria 28
New York 26
Rome 25
Santa Clara 25
Jakarta 20
Falkenstein 19
Nyköping 19
Seattle 18
Helsinki 17
Lauterbourg 17
Hanoi 16
Woodbridge 15
Columbus 14
Houston 14
São Paulo 14
Taranto 14
Cambridge 13
Frankfurt am Main 13
Ho Chi Minh City 13
Munich 13
Abidjan 12
Mexico City 12
Toronto 12
Boardman 11
Brooklyn 11
Naples 10
Nuremberg 10
Chicago 9
Montreal 9
North Bergen 8
Turku 8
Wilmington 8
Atlanta 7
Denver 7
Trieste 7
Brno 6
Buffalo 6
Chennai 6
Des Moines 6
Lawrence 6
London 6
Phoenix 6
Rio de Janeiro 6
Amsterdam 5
Ann Arbor 5
Brescia 5
Carrboro 5
Inglewood 5
Nakano 5
Portsmouth 5
Stockholm 5
Turin 5
Aldeatejada 4
Ankara 4
Baghdad 4
Casablanca 4
Dong Ket 4
Düsseldorf 4
Luton 4
Miano 4
Modugno 4
Moscow 4
Newark 4
Orem 4
Princeton 4
Shanghai 4
Tokyo 4
Albairate 3
Barletta 3
Bauru 3
Belo Horizonte 3
Bogotá 3
Boston 3
Brasília 3
Campinas 3
Caracas 3
Dublin 3
Goiânia 3
Guayaquil 3
Haiphong 3
Johannesburg 3
Miami 3
New Orleans 3
Philadelphia 3
Quận Bình Thạnh 3
Roxbury 3
Santa Maria 3
Santiago de Compostela 3
Totale 1.826
Salva come PNG Salva come JPEG
Nome #
Myasthenia Gravis Treatment: From Old Drugs to Innovative Therapies with a Glimpse into the Future 380
Dasatinib/HP-β-CD inclusion complex based aqueous formulation as a promising tool for the treatment of paediatric neuromuscular disorders 221
Ergogenic effect of bcaas and l-alanine supplementation: Proof-of-concept study in a murine model of physiological exercise 168
BCAAs and Di-Alanine supplementation in the prevention of skeletal muscle atrophy: preclinical evaluation in a murine model of hind limb unloading 168
LKB1 signaling is altered in skeletal muscle of a Duchenne muscular dystrophy mouse model 141
Growth hormone secretagogues modulate inflammation and fibrosis in mdx mouse model of Duchenne muscular dystrophy 135
β‐Dystroglycan Restoration and Pathology Progression in the Dystrophic mdx Mouse: Outcome and Implication of a Clinically Oriented Study with a Novel Oral Dasatinib Formulation 135
Ion channels as biomarkers of altered myogenesis in myofiber precursors of Duchenne muscular dystrophy 126
Circadian Genes as Exploratory Biomarkers in DMD: Results From Both the mdx Mouse Model and Patients 124
Branched-Chain Amino Acids and Di-Alanine Supplementation in Aged Mice: A Translational Study on Sarcopenia 122
Safety issues and harmful pharmacological interactions of nutritional supplements in Duchenne muscular dystrophy: considerations for Standard of Care and emerging virus outbreaks 121
Branched-chain amino acids and L-alanine supplementation ameliorate calcium dyshomeostasis in sarcopenia: New insights for nutritional interventions 117
Therapeutic Approaches to Tuberous Sclerosis Complex: From Available Therapies to Promising Drug Targets 114
Blockers of Skeletal Muscle Nav1.4 Channels: From Therapy of Myotonic Syndrome to Molecular Determinants of Pharmacological Action and Back. 113
Determination of qPCR reference genes suitable for normalizing gene expression in a novel model of Duchenne muscular dystrophy, the D2-mdx mouse 113
Preclinical study of the antimyotonic efficacy of safinamide in the myotonic mouse model 96
The Biallelic Inheritance of Two Novel SCN1A Variants Results in Developmental and Epileptic Encephalopathy Responsive to Levetiracetam 93
Preclinical Ultrasonography in Rodent Models of Neuromuscular Disorders: The State of the Art for Diagnostic and Therapeutic Applications 90
Myasthenia Gravis Treatment: From Old Drugs to Innovative Therapies with a Glimpse into the Future 86
PRE-CLINICAL ASSESSMENT OF THE ROLE OF THE COMPLEMENT SYSTEM IN TRIGGERING FIBROSIS IN DUCHENNE MUSCULAR DYSTROPHY: TOWARDS NOVEL THERAPEUTIC TARGETS 50
Pharmacological Therapies of Spinal Muscular Atrophy: A Narrative Review of Preclinical, Clinical–Experimental, and Real-World Evidence 49
Investigation of genotype-phenotype correlation in 2D cell models of Duchenne muscular dystrophy patients shows mutation-dependent defects in mitochondrial respiration and delay in myogenic program 48
A two-site collaborative study of electrical impedance myography for evaluation of disease progression in murine Duchenne muscular dystrophy models 41
Towards development of Nav1.7 channel modulators for pain treatment: A comparison of mexiletine effect in two cell models by automated patch clamp 38
SGLT2 inhibitor dapagliflozin mitigates skeletal muscle pathology by modulating key proteins involved in glucose and ion homeostasis in an animal model of heart failure 36
Natural history study of the D2-mdx mouse for Duchenne muscular dystrophy: a comparison across two independent study sites 36
Novel insights into the effects of JMV2894, a growth hormone secretagogue, in Duchenne muscular dystrophy: A preclinical study in the D2-mdx mouse model. 33
Branched-chain amino acid supplementation in a mouse model of ageing: Effects on age-related kidney fibrosis 29
Patient-Oriented In Vitro Studies in Duchenne Muscular Dystrophy: Validation of a 3D Skeletal Muscle Organoid Platform 29
Cell lines of Duchenne Muscular dystrophy patients shows mutation-dependent delay in myogenic program 28
Diaphragm‐specific effects of L‐citrulline in mdx mice highlight its potential as adjuvant of standard therapy in Duchenne muscular dystrophy 26
Electrical impedance myography as a tool for monitoring disease progression in mouse models of Duchenne Muscular Dystrophy: a longitudinal, multisite study 26
Best reference genes for unbiased normalized transcript expression in normal and dystrophic human cell models of myogenesis 23
254PActivation of complement cascade may trigger inflammation and fibrosis in Duchenne muscular dystrophy: a preclinical investigation on two murine models 23
Drug repurposing based on integrated in silico and in vitro approach to find a therapy for KCNA2-related disorders 10
From Symptomatic Therapies to Disease-Modifying Approaches for Neuronal Sodium Channel Disorders 9
Totale 3.197
Salva come PNG Salva come JPEG
Categoria #
all - tutte 11.339
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.339
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202246 0 0 0 0 0 2 8 0 5 7 11 13
2022/2023116 9 16 7 10 8 10 7 11 17 1 11 9
2023/2024101 2 16 7 10 6 17 1 4 7 15 6 10
2024/2025597 11 0 12 12 8 71 117 79 43 44 78 122
2025/20261.566 182 57 165 115 194 73 165 63 200 163 90 99
2026/2027634 165 95 165 209 0 0 0 0 0 0 0 0
Totale 3.197